Back to Dashboard
D7400C00006
Lymphoma
•
NCT04594642
•
Last updated: 2/17/2026
Recruiting
Study Design
Study Drug
AZD0486(TNB-486)
Mechanism of Action
CD19+CD3 bispecific Ab
Sponsor
Unknown
Design
I
Control Arm
-
Criteria
Inclusion Criteria
1. R/R 2. ≥2 prior Tx
Age: Phase: I
Exclusion Criteria
Enrollment
Progress
3 / 5
Contact Information
Principal Investigator
Unknown
Study Nurse
鄭采涵
Contact Tel
3974